IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment

Go back to IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment
(NASDAQ: ICCM) Delayed: 2.21 -0.02 (0.9%)
Previous Close $2.23    52 Week High
Open $2.25    52 Week Low
Day High $2.25    P/E N/A 
Day Low $2.14    EPS
Volume 54,005